Study Evaluating Pantoprazole in Children With Gastroesophageal Reflux Disease (GERD)

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2008

Conditions
Gastroesophageal Reflux
Interventions
DRUG

pantoprazole sodium enteric-coated spheroid

pediatric spheroids taken daily x 8 weeks

Trial Locations (43)

10032

New York

14222

Buffalo

19104

Philadelphia

19803

Wilmington

20010

Washington D.C.

23507

Norfolk

25304

Charleston

32207

Jacksonville

32504

Pensacola

32610

Gainesville

32806

Orlando

33101

Miami

36604

Mobile

39216

Jackson

40202

Louisville

40536

Lexington

48075

Southfield

48503

Flint

53215

Milwaukee

61603

Peoria

68105

Omaha

73104

Oklahoma City

76508

Temple

77030

Houston

85016

Phoenix

89102

Las Vegas

92103

San Diego

92868

Orange

94609

Oakland

95819

Sacramento

02114

Boston

02115

Boston

08234

Egg Harbor

07962

Morristown

17822-1320

Danville

25701-3655

Huntington

T6G 2B7

Edmonton

A1B 3V6

St. John's

L8N 3Z5

Hamilton

N6A 4G5

London

K1H 8L1

Ottawa

H3H 1P3

Montreal

H3T 1C5

Montreal

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Nycomed

INDUSTRY

lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY